Catalyst Wire Dossier Catalyst Wire Dossier

RBP-6000

buprenorphine · Indivior Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RBP-6000, covering 2016-05-09 to 2016-12-26. Get the full timeline:

Most recent: Clinical Trial Update: Single Ascending Dose Study of RBP-6000 [Phase 1]

See pricing